Seroatlas · Human Serome Atlas

BCL2L15

Bcl-2-like protein 15

Also known as: B2L15_HUMAN, Bfk, C1orf178, FLJ22588

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q5TBC7
Gene
BCL2L15
Ensembl
ENSG00000188761
Chromosome
1
Canonical length
163 aa
Protein class
Predicted intracellular proteins

OverviewNCBI Gene

Predicted to be involved in apoptotic process and regulation of apoptotic process. Predicted to be active in cytosol and nucleus. [provided by Alliance of Genome Resources, Jul 2025]

Canonical amino-acid sequenceUniProt

163 residues, UniProt reviewed canonical sequence.

>Q5TBC7|BCL2L15
     1  MKSSQTFEEQ TECIVNTLLM DFLSPTLQVA SRNLCCVDEV DSGEPCSFDV AIIAGRLRML
    61  GDQFNGELEA SAKNVIAETI KGQTGAILQD TVESLSKTWC AQDSSLAYER AFLAVSVKLL
   121  EYMAHIAPEV VGQVAIPMTG MINGNQAIRE FIQGQGGWEN LES

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against BCL2L15 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.33
Highest tissue expression
41 nTPM

Expression across tissuesHPA

Tissue

  • duodenum: 41 nTPM
  • small intestine: 39 nTPM
  • colon: 30 nTPM
  • rectum: 25 nTPM
  • stomach: 17 nTPM
  • bone marrow: 13 nTPM

Single-cell type

  • enterocytes: 145 nCPM
  • gastric progenitor cells: 123 nCPM
  • colonocytes: 92 nCPM
  • neutrophil progenitors: 75 nCPM
  • enteric transient amplifying cells: 67 nCPM
  • endometrial secretory cells: 61 nCPM

Immune cell

  • neutrophil: 0.4 nTPM
  • memory CD4 T-cell: 0.2 nTPM
  • MAIT T-cell: 0.1 nTPM
  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM

Brain region

  • cerebellum: 5.9 nTPM
  • pons: 3.8 nTPM
  • cerebral cortex: 3.5 nTPM
  • hippocampal formation: 3.2 nTPM
  • basal ganglia: 3.1 nTPM
  • hypothalamus: 3.1 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.1
gnomAD pLI
0.05
gnomAD missense Z
0.25
DepMap mean gene effect
-0.1
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads BCL2L15 as an antibody target. Whether an autoantibody or antibody against BCL2L15 could matter depends on whether native BCL2L15 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

BCL2L15 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label BCL2L15 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/BCL2L15. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...